Feb 9, 2025 · The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use …

About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide …

Jan 1, 2015 · The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and …

Access to appropriate medications is shown to have substantial impacts on community health and the related economic indicators. Quality-assured, safe and effective medicines, vaccines and …

Apr 15, 2025 · The World Health Organization (WHO) today released its Consolidated guidelines on tuberculosis (TB)- Module 4: treatment and care, consolidating all previous guidelines into a …

May 17, 2024 · The World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria …

Apr 15, 2025 · Module 4: treatment and care encompass all current recommendations for managing drug-susceptible and drug-resistant TB, alongside patient care and support …

In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their …

Apr 1, 2025 · This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development. It covers systemic antifungal drugs in …

Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good …